
Merck funds tests of lower Zilmax doses
Chicago | Reuters –– Merck and Co. is funding the testing of lower dosages of its controversial cattle growth drug Zilmax, in a move livestock experts say is crucial if the company is to resume sales of the product to the U.S. beef industry. Nearly 18 months after Merck pulled […]